Arqule Inc (ARQL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARQL | SMMT | CORT | ||
| Company | Arqule Inc | Summit Therapeu ADR | Corcept Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 20.00 | 3.50 | 22.60 | ||
| High | 20.00 | 3.55 | 23.03 | ||
| Low | 19.98 | 3.34 | 22.56 | ||
| Last | 20.00 | 3.50 | 22.95 | ||
| Change | +0.03 | -0.01 | +0.29 | ||
| % Change | +0.15% | -0.28% | +1.28% | ||
| Volume | 6,172,600 | 1,728,400 | 924,700 | ||
| 20-Day Average Volume | 4,217,200 | 2,025,400 | 780,750 | ||
| Previous Close | 19.97 | 3.51 | 22.66 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 20.06 | 3.75 | 24.37 | ||
| 20-Day Raw Stochastic | 14.29% | 17.99% | 11.02% | ||
| 20-Day Relative Strength | 79.87% | 44.27% | 44.07% | ||
| Weighted Alpha | +142.50 | +77.34 | -1.12 | ||
| Today's Opinion | 88% Buy | 24% Buy | 88% Sell | ||
| Previous Opinion | 88% Buy | 24% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 64% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.10% since 01/08/20 | -4.50% since 04/12/24 | -2.38% since 04/12/24 | ||
| Low | 19.97 on 01/14/20 | 3.34 on 04/19/24 | 22.56 on 04/19/24 | ||
| High | 20.02 on 01/10/20 | 3.80 on 04/15/24 | 23.65 on 04/16/24 | ||
| 1-Month | |||||
| %Chg | -0.32% since 12/13/19 | -3.58% since 03/19/24 | -5.36% since 03/19/24 | ||
| Low | 19.93 on 01/02/20 | 3.25 on 03/22/24 | 22.56 on 04/19/24 | ||
| High | 20.42 on 12/19/19 | 4.64 on 03/28/24 | 26.10 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | +131.62% since 10/15/19 | -3.05% since 01/19/24 | -6.02% since 01/19/24 | ||
| Low | 6.98 on 11/06/19 | 3.25 on 03/22/24 | 20.87 on 02/02/24 | ||
| High | 20.45 on 12/11/19 | 5.22 on 03/05/24 | 26.10 on 04/01/24 | ||
| 6-Month | |||||
| %Chg | +88.68% since 07/15/19 | +90.22% since 10/19/23 | -18.04% since 10/19/23 | ||
| Low | 6.79 on 09/30/19 | 1.64 on 11/09/23 | 20.87 on 02/02/24 | ||
| High | 20.45 on 12/11/19 | 5.22 on 03/05/24 | 33.28 on 12/28/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,417,460 | 2,462,978 | 2,345,763 | ||
| Shares Outstanding, K | 120,873 | 701,703 | 103,520 | ||
| Annual Sales | 25,760,000 | 0 | 482,380,000 | ||
| Annual Net Income | -15,480,000 | -614,930,000 | 106,140,000 | ||
| Last Quarter Sales | 210,000 | 0 | 135,410,000 | ||
| Last Quarter Net Income | -10,740,000 | -36,570,000 | 31,360,000 | ||
| 60-Month Beta | 2.49 | -1.21 | 0.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.04 on 02/20/24 | 0.28 on 02/15/24 | ||
| Latest Earnings Date | 03/05/20 | 05/09/24 | 05/01/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 24.21 | ||